First-generation antipsychotic (substituted benzamide)
Sulpiride
Brand names: Dolmatil, Sulpor
Adult dose
Dose: Schizophrenia: 200–400mg PO BD (max 2.4g/day). Tourette's: 100–400mg PO BD
Route: PO
Frequency: BD
Dose adjustments
Renal
Reduce in renal impairment
Clinical pearls
- Schizophrenia, Tourette's
- Less sedating; high-dose required for psychosis
Contraindications
- Phaeochromocytoma
- Prolactin-dependent tumour
- Acute porphyria
Side effects
- EPS
- Sedation
- Hyperprolactinaemia (very common — galactorrhoea, amenorrhoea)
- QT prolongation
- Weight gain
- Anticholinergic effects (less than typicals)
Interactions
- QT-prolonging drugs
- Levodopa
- Antacids (separate)
Monitoring
- ECG
- Glucose
- Lipids
- Prolactin
- Weight
Reference: BNF; NICE CG178; https://bnf.nice.org.uk/drugs/sulpiride/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185 / BNF